Journal ArticleOPEN ACCESS

Impact of Biologic Agents on the Immune Response Induced by the Additional Dose of SARS-CoV-2 Vaccine in Inflammatory Bowel Disease Patients

Inflammatory Bowel Diseases (2023) 29(7) 1165-1169
DOI: 10.1093/ibd/izac228
4Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

The immusne response to the vaccine against SARS-CoV-2 is altered in patients with inflammatory bowel disease using biological agents, and so we should ensure effective immunization in these patients by prioritizing those receiving anti-Tumor necrosis factor agents in the indication of new doses or booster doses of the vaccine.

Cite

CITATION STYLE

APA

Ramos, L., Hernández-Porto, M., Carrillo-Palau, M., Alonso-Abreu, I., Reygosa, C., & Hernandez-Guerra, M. (2023). Impact of Biologic Agents on the Immune Response Induced by the Additional Dose of SARS-CoV-2 Vaccine in Inflammatory Bowel Disease Patients. Inflammatory Bowel Diseases, 29(7), 1165–1169. https://doi.org/10.1093/ibd/izac228

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free